United American Securities Inc. (D Bristol Myers Squibb CO Transaction History

United American Securities Inc. (D

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2023	BUY	$72.62 - $79.98 $363,100 - $399,900	5,000 New	5,000 $385,000
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $363,100 - $399,900	5,000 New	5,000 $385,000
Q1 2019 May 14, 2019	SELL	$45.12 - $53.8 $800,880 - $954,950	-17,750 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $865,490 - $1.12 Million	17,750 New	17,750 $923,000
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $176,855 - $220,430	-3,500 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$59.92 - $68.98 $988,680 - $1.14 Million	-16,500 Reduced 82.5%	3,500 $221,000
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $1.2 Million - $1.31 Million	20,000	20,000 $1.23 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of United American Securities Inc. (D, based on Form 13F filings with the SEC.

Stay updated on United American Securities Inc. (D with notifications on news.